Kathy Bowen, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 400 John Ave Se, Attalla, AL 35954 Phone: 256-458-6918 |
News Archive
The U.S. Food and Drug Administration today approved Brisdelle (paroxetine) to treat moderate to severe hot flashes (vasomotor symptoms) associated with menopause. Brisdelle, which contains the selective serotonin reuptake inhibitor paroxetine mesylate, is currently the only non-hormonal treatment for hot flashes approved by the FDA.
A new preprint recently released on the bioRxiv* server describes the immunogenicity and protective potential of a novel adenovirus SARS-CoV-2 vaccine candidate against a form of the virus adapted to cause severe disease in mice. The findings show that this provides a useful mouse model for the study of new vaccines, in addition to demonstrating the protective efficacy of the current rhesus adenovirus vaccine candidate RhAd52.
The Associated Press reports that people with HIV/AIDS have a lot at stake regarding the health law's future - specifically, its Medicaid expansion and ban on pre-existing condition exclusions. In a second story, though, AP reports on why the small business group, the NFIB, hopes to see the law overturned. Meanwhile, MarketWatch reports that some wealthy Americans would save big money if the high court rejects the overhaul.
METTLER TOLEDO is pleased to present its 2017 limited-edition, full-color lab calendar. A welcome addition to any lab or office, this attractive 12-month calendar includes access to a series of free resources from eLearning modules to white papers, each of which is devoted to ensuring accuracy in all critical lab processes.
Dr. Gary R. Matyas has been selected the 2012 recipient of the NIDA Avant-Garde Award for Medications Development. Matyas proposes to develop an effective, safe and easily manufactured combination anti-heroin/HIV vaccine that could treat heroin addiction while at the same time prevent HIV infection in those receiving the vaccine.
› Verified 1 days ago